✦ LIBER ✦

Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy

✍ Scribed by Michael R. Detty; Scott L. Gibson; Stephen J. Wagner

Publisher: John Wiley and Sons
Year: 2004
Weight: 10 KB
Volume: 35
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200440261

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Porphyrin-Based Pho

ChemInform Abstract: Porphyrin-Based Photosensitizers for Use in Photodynamic Therapy

✍ E. D. STERNBERG; D. DOLPHIN; C. BRUECKNER 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

New Amphiphilic Silicon(IV) Phthalocyani

New Amphiphilic Silicon(IV) Phthalocyanines as Efficient Photosensitizers for Photodynamic Therapy: Synthesis, Photophysical Properties, and in vitro Photodynamic Activities

✍ Pui-Chi Lo; Jian-Dong Huang; Diana Y. Y. Cheng; Elaine Y. M. Chan; Wing-Ping Fon 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 1 views

Targeting of a hydrophilic photosensitiz

Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy

✍ Maarten B. Vrouenraets; Gerard W.M. Visser; Christophe Loup; Bernard Meunier; Ma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 140 KB 👁 2 views

Coupling of photosensitizers to tumor-selective monoclonal antibodies (MAbs) is an attractive option for improving the selectivity of photodynamic therapy (PDT). For this purpose, hydrophilic sensitizers would be most suitable because of their solubility in water. However, such sensitizers are known

Preclinical and Clinical Practice of Low

Preclinical and Clinical Practice of Low-Dose FP Therapy in Japan: Japanese Use of Low-Dose FP Therapy

✍ Tetsuhiko Shirasaka; Akihito Tsuji; Susumu Yamamitsu; Tetsuo Taguchi 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 51 KB

Comparative biodistribution of meta-Tetr

Comparative biodistribution of meta-Tetra (Hydroxyphenyl) chlorin in multiple species: Clinical implications for photodynamic therapy

✍ Ronn, Avigdor M.; Batti, James; Lee, Catherine J.; Yoo, Don; Siegel, Michelle E. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

## Background and objective: To optimize photodynamic therapy, it is necessary to know the distribution of photosensitizer in normal tissue as well as tumors and to know how well animal models match human. this study measured the biodistribution of meta-tetra(hydroxyphenyl) chlorin (mthpc) in three

The Disease Activity Score is not suitab

The Disease Activity Score is not suitable as the sole criterion for initiation and evaluation of anti–tumor necrosis factor therapy in the clinic: Discordance between assessment measures and limitations in questionnaire use for regulatory purposes

✍ Frederick Wolfe; Kaleb Michaud; Theodore Pincus; Daniel Furst; Edward Keystone 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

## Abstract ## Objective The Disease Activity Score (DAS) is widely used in clinical trials. A DAS of 5.1 defines the level of severe rheumatoid arthritis (RA) and is the criterion for the initiation of anti–tumor necrosis factor therapy in the UK and The Netherlands. In North America, similar rul